Although typically considered second-line therapy, SGLT2 inhibitors may have a role as initial pharmacological treatment in type 2 diabetes in conjunction with metformin in appropriately selected patients (Donnan 2019
Based on our alanine screening, we aimed to optimize the sequence of p53 TAD PEP to improve its cell permeability
Q7: Why use CJC-1295 without DAC instead of the with-DAC version
The ominous octet (Defronzo model) includes: decreased muscle glucose uptake, increased hepatic glucose output, impaired incretin effect, alpha-cell hyperglucagonemia, increased renal glucose reabsorption (SGLT-2 upregulation), increased lipolysis (adipose), decreased central satiety signaling, and decreased beta-cell insulin secretion
Mitochondrion 7(Suppl.), S168S174